Oncura, Inc
Minimally Invasive Treatment Options
Brachytherapy
Oncura
Clinical Outcomes Reimbursement Patients Investors
The Oncura Story Glossary Contact

News

2006

May 1, 2006
Healthtrust Purchasing Group selects ONCURA™ to provide membership with prostate brachytherapy products under a new three-year agreement

January 31, 2006
ONCURA™ Wins Contract for The Cookridge Hospital’s Prostate Brachytherapy Seed Business

2005

August 19, 2005
Amerinet selects ONCURA™ to provide Prostate Brachytherapy products under a new three-year agreement

July 21, 2005
ONCURA™ Announces an Agreement with North American Scientific Inc. for the Distribution of Prospera® Palladium-103 Prostate Brachytherapy Sources

June 13, 2005
ONCURA™ Announces French Reimbursement for Their Leading
Prostate Cancer Treatment Products.

June 1, 2005
ONCURA™ Expands its Product Line with RAPID Strand™ Rx.

2004

December 10, 2004
ONCURA™ Confirms That They Will Not Renew US Distribution Agreement with Theragenics™ When it Expires in December 2005.

December 9, 2004
Clinical Study Demonstrates that ONCURA's RAPID Strand™ Offers Improved Delivery of Therapy for Patients Choosing Brachytherapy to Treat Prostate Cancer.

November 24, 2004
The European Collaborative Group on Prostate Brachytherapy Reports on over 1150 Patients Treated with Oncura's RAPID Strand™.

October 28, 2004
Oncura™ elevated to the status of Ambassador Supporter by the American Society of Therapeutic Radiology and Oncology (ASTRO).

October 5, 2004
Long-term data presentated by the New York Prostate Institute and utilizing ONCURA's OncoSeed™ reinforces the value of Prostate Brachytherapy.

June 9, 2004
Premier selects Oncura to provide membership with exclusive prostate brachytherapy products under two new three-year agreements.

May 25, 2004
New data presented at the annual meeting of the American Brachytherapy Society demonstrates the value of RAPID Strand™ as a treatment for localized prostate cancer.

May 11, 2004
Long-term data utilizing ONCURA’s OncoSeed™ reinforces the value of Iodine-125 prostate brachytherapy.

April 28, 2004
Long term cancer survival data utilizing ONCURA's OncoSeed™ reinforces brachytherapy's position as standard of care for treating prostate cancer.

2003

October 02, 2003
RAPID Strand™ offers increased clinical confidence to prostate cancer patients treated with brachytherapy.

July 08, 2003
Merger Creates ONCURA, a Global Leader in Minimally Invasive Prostate Cancer Disease Management.


 

Print this Page